Vaishali Pharma Limited (VAISHALI)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
82.45
0.2(0.24%)

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

83.9

TODAY'S LOW

81.5

52 WEEK HIGH

119.3

52 WEEK LOW

28.95

Major Holders

% of Shares Held by
All Insider

nan

% of Shares Held by
Institutions

nan

% of Float Held by
Institutions

nan

Number of Institutions
Holding Shares

nan

Company Overview

MARKET CAP

86.95 Cr.

ETERPRISE VALUE

107.24 Cr.

NO. OF SHARES

1.05 Cr.

BOOK VALUE

24.691

DIV. YIELD

None%

DEBT

20.81 Cr.

GROSS PROFIT

12.32 Cr.

CASH

1.35 Cr.

REVENUE

75.82 Cr.

REVENUE/SHARE

71.984

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments0000
Change To Liabilities-12.10 Cr.17.05 Cr.-89.32 Lakhs2.14 Cr.
Total cashflows from Investing Activities-84.68 Lakhs-11.03 Lakhs-1.93 Lakhs-28.45 Lakhs
Net Borrowings2.96 Cr.80.54 Lakhs-60.99 Lakhs-1.31 Cr.
Total Cash from Financing Activities41.76 Lakhs-1.81 Cr.-3.13 Cr.-3.99 Cr.
Other Liabilities-1.22 Cr.1.39 Cr.-7.81 Lakhs3.42 Cr.
Total Assets0000
Net Income4.02 Cr.1.04 Cr.3.27 Lakhs71.35 Lakhs
Change in Cash88.93 Lakhs8.91 Lakhs6.05 Lakhs3.59 Lakhs
Effect of Exchange Rate0000
Total Cash from Operating Activities1.31 Cr.2.01 Cr.3.21 Cr.4.31 Cr.
Depreciation45.63 Lakhs42.43 Lakhs43.67 Lakhs26.56 Lakhs
Other Cashflows from Investing Activities1.80 Lakhs1.56 Lakhs3.32 Lakhs1.17 Lakhs
Dividends Paid0000
Change to Inventory-4.07 Lakhs29.18 Lakhs10.12 Lakhs88.67 Lakhs
Change to Account Receivables8.22 Cr.-21.52 Cr.-1.04 Cr.-4.84 Cr.
Other Cashflows from Financing Activities-2.54 Cr.-2.61 Cr.-2.52 Cr.-2.67 Cr.
Change to Net Income1.99 Cr.3.31 Cr.4.66 Cr.1.71 Cr.
Capital Expenditures-86.48 Lakhs-12.60 Lakhs-5.26 Lakhs-29.62 Lakhs

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax5.72 Cr.1.40 Cr.7.91 Lakhs1.13 Cr.
Minority InterestNoneNoneNoneNone
Net Income6.39 Cr.2.22 Cr.46.28 Lakhs1.81 Cr.
Selling General Administrative2.09 Cr.1.93 Cr.2.20 Cr.2.64 Cr.
Gross Profit12.32 Cr.7.60 Cr.8.97 Cr.6.39 Cr.
Ebit6.39 Cr.2.22 Cr.46.28 Lakhs1.81 Cr.
Operating Income6.39 Cr.2.22 Cr.46.28 Lakhs1.81 Cr.
Other Operating Expenses3.36 Cr.1.19 Cr.2.40 Cr.1.67 Cr.
Interest Expense-2.45 Cr.-2.62 Cr.-2.55 Cr.-2.66 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense1.70 Cr.35.82 Lakhs4.63 Lakhs41.88 Lakhs
Total Revenue75.82 Cr.53.77 Cr.60.08 Cr.75.09 Cr.
Total Operating Expenses69.42 Cr.51.55 Cr.59.62 Cr.73.27 Cr.
Cost of Revenue63.50 Cr.46.16 Cr.51.10 Cr.68.69 Cr.
Total Other Income Expense Net-67.07 Lakhs-81.65 Lakhs-38.37 Lakhs-67.95 Lakhs
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.4.02 Cr.1.04 Cr.3.27 Lakhs71.35 Lakhs
Net Income Applicable to Common Shares4.02 Cr.1.04 Cr.3.27 Lakhs71.35 Lakhs

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets76.92 Lakhs29.35 Lakhs39.67 Lakhs49.48 Lakhs
Capital Surplus08.20 Cr.8.20 Cr.12.19 Cr.
Total Liabilities55.26 Cr.63.70 Cr.44.82 Cr.47.35 Cr.
Stock Holder Equity26.35 Cr.22.41 Cr.21.38 Cr.21.39 Cr.
Minority Interest0000
Other Liabilities5.28 Cr.2.48 Cr.1.86 Cr.3.02 Cr.
Total Assets81.62 Cr.86.12 Cr.66.20 Cr.68.75 Cr.
Common Stock10.54 Cr.10.54 Cr.10.54 Cr.6.59 Cr.
Retained Earnings03.56 Cr.2.51 Cr.2.48 Cr.
Other Liabilities18.92 Lakhs18.49 Lakhs13.88 Lakhs9.41 Lakhs
Good Will0000
Treasury Stock15.80 Cr.10.50 Lakhs11.41 Lakhs12.64 Lakhs
Other Assets3.09 Cr.2.48 Cr.2.34 Cr.3.32 Cr.
Cash1.35 Cr.31.34 Lakhs28.32 Lakhs22.99 Lakhs
Current Liabilities51.93 Cr.59.26 Cr.40.41 Cr.42.47 Cr.
Long Term Asset Charges16.07 Lakhs14.80 Lakhs12.42 Lakhs10.96 Lakhs
Short Long Term Debt17.65 Cr.1.91 Cr.95.93 Lakhs84.67 Lakhs
Other Stockholder Equity15.80 Cr.10.50 Lakhs11.41 Lakhs12.64 Lakhs
Property Plant Equipment90.36 Lakhs97.06 Lakhs1.16 Cr.87.84 Lakhs
Total Cur. Assets76.42 Cr.81.29 Cr.61.20 Cr.62.97 Cr.
Long Term Investments43.15 Lakhs1.08 Cr.1.08 Cr.1.08 Cr.
Net Tangible Assets25.58 Cr.22.12 Cr.20.98 Cr.20.90 Cr.
Short Term Investments0000
Net Receivables58.50 Cr.67.21 Cr.47.25 Cr.49.85 Cr.
Long Term Debt3.10 Cr.4.03 Cr.4.05 Cr.4.77 Cr.
Inventory62.90 Lakhs58.82 Lakhs88 Lakhs98.12 Lakhs
Accounts Payable28.38 Cr.40.53 Cr.23.63 Cr.24.52 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account